Evidence map›Paper›PMID 8611396›Full record

ArticleBritish journal of cancer1996

3-methyladenine-DNA-glycosylase and O6-alkyl guanine-DNA-alkyltransferase activities and sensitivity to alkylating agents in human cancer cell lines.

G Damia, L Imperatori, L Citti, L Mariani, M D'Incalci

Open access · bronzeAbstract read
In one paragraph

Article in British journal of cancer, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 19 citations in OpenAlex.

  1. Relationship Between the Expression of OClinical drug investigation · 2017
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

G DamiaIstituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
L Imperatori
L Citti
L Mariani
M D'Incalci
Mario Negri Institute for Pharmacological Research · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The activities and the expression of 3-methyladenine glycosylase (3-meAde gly) and O6-alkylguanine-DNA-alkyltransferase (O6 ATase) were investigated in ten human cancer cell lines. Both 3-meAde gly and O6 ATase activities were variable among different cell lines. mRNA levels of the O6 ATase gene, appeared to be related to the content of O6 ATase in different cell lines, whereas no apparent correlation was found between mRNA of 3-meAde gly and the enzyme activity. No correlation was found between the activity of the two enzymes and the sensitivity to alkylating agents of different structures such as CC-1065, tallimustine, dimethylsulphate (DMSO), N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), cis-diamminedichloroplatinum (cDDP) and melphalan (L-PAM). The most striking finding of this study is that a correlation exists between the activity of O6 ATase and 3-meAde gly in the various cell lines investigated (P<0.01), suggesting a common mechanism of regulation of two DNA repair enzymes.

Indexed as

DNA GlycosylasesAlkylating AgentsAntineoplastic Agents, AlkylatingCarcinogensCell DivisionCisplatinDistamycinsHumansMelphalanMethylnitronitrosoguanidineMethyltransferasesNeoplasmsN-Glycosyl HydrolasesNitrogen Mustard CompoundsO(6)-Methylguanine-DNA MethyltransferaseRNA, Messenger3-methyladenine-DNA glycosylaseAlkylating AgentsAntineoplastic Agents, AlkylatingCarcinogensCisplatindimethyl sulfateDistamycinsDNA GlycosylasesMelphalanMethylnitronitrosoguanidineMethyltransferasesN-Glycosyl HydrolasesNitrogen Mustard CompoundsO(6)-Methylguanine-DNA MethyltransferaseRNA, MessengerSulfuric Acid Esterstallimustine

Identifiers

PMID8611396
PMCPMC2074260
OpenAlexW2011819340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.